Robert M. Straubinger

6.8k total citations
127 papers, 5.2k citations indexed

About

Robert M. Straubinger is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Robert M. Straubinger has authored 127 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 52 papers in Oncology and 28 papers in Biomaterials. Recurrent topics in Robert M. Straubinger's work include Nanoparticle-Based Drug Delivery (28 papers), Pancreatic and Hepatic Oncology Research (24 papers) and Cancer Treatment and Pharmacology (16 papers). Robert M. Straubinger is often cited by papers focused on Nanoparticle-Based Drug Delivery (28 papers), Pancreatic and Hepatic Oncology Research (24 papers) and Cancer Treatment and Pharmacology (16 papers). Robert M. Straubinger collaborates with scholars based in United States, Ireland and United Kingdom. Robert M. Straubinger's co-authors include Demetrios Papahadjopoulos, Sathyamangalam V. Balasubramanian, Amarnath Sharma, Keelung Hong, Donald E. Mager, Daniel S. Friend, Nejat Düzgüneş, Jun Qu, Yu‐Kyoung Oh and William J. Jusko and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Robert M. Straubinger

125 papers receiving 5.0k citations

Peers

Robert M. Straubinger
M. Guillaume Wientjes United States
L.D. Mayer Canada
Luigi Cattel Italy
Rodney J. Y. Ho United States
Gerrit L. Scherphof Netherlands
E. Mayhew United States
Didier Desmaële France
Francisco J. Plaza Martín Spain
Lawrence D. Mayer Canada
Thomas D. Madden Canada
M. Guillaume Wientjes United States
Robert M. Straubinger
Citations per year, relative to Robert M. Straubinger Robert M. Straubinger (= 1×) peers M. Guillaume Wientjes

Countries citing papers authored by Robert M. Straubinger

Since Specialization
Citations

This map shows the geographic impact of Robert M. Straubinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Straubinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Straubinger more than expected).

Fields of papers citing papers by Robert M. Straubinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Straubinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Straubinger. The network helps show where Robert M. Straubinger may publish in the future.

Co-authorship network of co-authors of Robert M. Straubinger

This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. Straubinger. A scholar is included among the top collaborators of Robert M. Straubinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. Straubinger. Robert M. Straubinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stachowiak, Ewa K., Spencer R. Rosario, Joseph A. Spernyak, et al.. (2024). Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors. Clinical Cancer Research. 30(7). 1367–1381. 1 indexed citations
2.
3.
Miao, Xin, Gilbert Koch, Shichen Shen, et al.. (2023). Systems Pharmacodynamic Model of Combined Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways. Journal of Pharmaceutical Sciences. 113(1). 235–245. 3 indexed citations
4.
Sun, Boyang, Dushyant Jahagirdar, Dandan Luo, et al.. (2022). Single-treatment tumor ablation with photodynamic liposomal irinotecan sucrosulfate. Translational Oncology. 19. 101390–101390. 11 indexed citations
5.
6.
Jusko, William J., et al.. (2021). Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation. Journal of Pharmacology and Experimental Therapeutics. 377(3). 370–384. 5 indexed citations
7.
Wang, Jun, et al.. (2019). Tumor Priming by SMO Inhibition Enhances Antibody Delivery and Efficacy in a Pancreatic Ductal Adenocarcinoma Model. Molecular Cancer Therapeutics. 18(11). 2074–2084. 24 indexed citations
8.
Luo, Dandan, Kevin A. Carter, Jumin Geng, et al.. (2019). Pharmacokinetics and pharmacodynamics of liposomal chemophototherapy with short drug-light intervals. Journal of Controlled Release. 297. 39–47. 56 indexed citations
9.
Pace, Emily A., Sharlene Adams, Michael D. Curley, et al.. (2018). Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer. Clinical Cancer Research. 24(12). 2873–2885. 44 indexed citations
10.
Nguyen, Juliane, Shaolie S. Hossain, Jason A. Ellis, et al.. (2017). Flow arrest intra-arterial delivery of small TAT-decorated and neutral micelles to gliomas. Journal of Neuro-Oncology. 133(1). 77–85. 9 indexed citations
11.
Hylander, Bonnie L., et al.. (2015). Tumor-Priming Smoothened Inhibitor Enhances Deposition and Efficacy of Cytotoxic Nanoparticles in a Pancreatic Cancer Model. Molecular Cancer Therapeutics. 15(1). 84–93. 29 indexed citations
12.
Harrold, John M., Robert M. Straubinger, & Donald E. Mager. (2012). Combinatorial Chemotherapeutic Efficacy in Non-Hodgkin Lymphoma Can Be Predicted by a Signaling Model of CD20 Pharmacodynamics. Cancer Research. 72(7). 1632–1641. 25 indexed citations
13.
Ait‐Oudhia, Sihem, Robert M. Straubinger, & Donald E. Mager. (2012). Meta-analysis of Nanoparticulate Paclitaxel Delivery System Pharmacokinetics and Model Prediction of Associated Neutropenia. Pharmaceutical Research. 29(10). 2833–2844. 20 indexed citations
14.
15.
Purohit, Vivek S., et al.. (2008). Passive Transfer of Polyethylene Glycol to Liposomal-Recombinant Human FVIII Enhances its Efficacy in a Murine Model for Hemophilia A. Journal of Pharmaceutical Sciences. 97(9). 3753–3764. 12 indexed citations
16.
Straubinger, Robert M. & Sathyamangalam V. Balasubramanian. (2005). Preparation and Characterization of Taxane-Containing Liposomes. Methods in enzymology on CD-ROM/Methods in enzymology. 391. 97–117. 40 indexed citations
17.
Edgerton, Mira, et al.. (1998). Candidacidal Activity of Salivary Histatins. Journal of Biological Chemistry. 273(32). 20438–20447. 175 indexed citations
18.
Balasubramanian, Sathyamangalam V., et al.. (1995). Pharmaceutical and Physical Properties of Paclitaxel (Taxol †) Complexes with Cyclodextrins ‡. Journal of Pharmaceutical Sciences. 84(10). 1223–1230. 148 indexed citations
19.
Balasubramanian, Sathyamangalam V., James L. Alderfer, & Robert M. Straubinger. (1994). Solvent- and Concentration-Dependent Molecular Interactions of Taxol (Paclitaxel †). Journal of Pharmaceutical Sciences. 83(10). 1470–1476. 52 indexed citations
20.
Straubinger, Robert M.. (1993). [28] pH-sensitive liposomes for delivery of macromolecules into cytoplasm of cultured cells. Methods in enzymology on CD-ROM/Methods in enzymology. 221. 361–376. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Guillaume Wientjes Breakdown of academic impact, for papers by L.D. Mayer Breakdown of academic impact, for papers by Luigi Cattel Breakdown of academic impact, for papers by Rodney J. Y. Ho Breakdown of academic impact, for papers by Gerrit L. Scherphof Breakdown of academic impact, for papers by E. Mayhew Breakdown of academic impact, for papers by Didier Desmaële Breakdown of academic impact, for papers by Francisco J. Plaza Martín Breakdown of academic impact, for papers by Lawrence D. Mayer Breakdown of academic impact, for papers by Thomas D. Madden
Rankless by CCL
2026